466 Next generation sequencing of BRCA1 and BRCA2 genes in ovarian tumors captures all germline mutations and expands the potential treatment group for the PARP inhibitor olaparib. (September 2015) - Timms, K.; Neff, C.; Morris, B.; Hodgson, D.; Orr, M.; Zhongwu, L.; Fielding, A.; Dougherty, B.; Spencer, S.; Robertson, J.; Barrett, C.; Gutin, A.; et al.